Xylosyltransferase I acceptor properties of fibroblast growth factor and its fragment bFGF (1-24)

Biochemical and Biophysical Research Communications

Volumn 333, Issue 1, 2005, Pages 156-166

  Kuhn, Joachim ^a   Schnölzer, Martina ^b   Schön, Sylvia ^a   Müller, Sandra ^a   Prante, Christian ^a   Götting, Christian ^a   Kleesiek, Knut ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Basic fibroblast growth factor; Heparin; Xylosyltransferase

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; TRANSFERASE; UNCLASSIFIED DRUG; XYLOSYLTRANSFERASE I;

ARTICLE; BODY FLUID; CONTROLLED STUDY; ENZYME ACTIVITY; GENE SEQUENCE; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; BINDING SITES; ENZYME ACTIVATION; FIBROBLAST GROWTH FACTOR 2; MOLECULAR SEQUENCE DATA; PENTOSYLTRANSFERASES; PEPTIDE FRAGMENTS; PROTEIN BINDING;

EID: 20444433087     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.05.087     Document Type: Article

References (42)

1. T. Brinkmann, C. Weilke, and K. Kleesiek Recognition of acceptor proteins by UDP-d-xylose proteoglycan core protein β-d-xylosyltransferase J. Biol. Chem. 272 1997 11171 11175
2. C. Weilke, T. Brinkmann, and K. Kleesiek Determination of xylosyltransferase activity in serum with recombinant human bikunin as acceptor Clin. Chem. 43 1997 45 51
3. P. Bashkin, S. Doctrow, M. Klagsbrun, C.M. Svahn, J. Folkman, and I. Vlodavsky Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules Biochemistry 28 1989 1737 1743
4. J.A. Buczek-Thomas, and M.A. Nugent Elastase-mediated release of heparan sulfate proteoglycans from pulmonary fibroblast cultures. A mechanism for basic fibroblast growth factor (bFGF) release and attenuation of bfgf binding following elastase-induced injury J. Biol. Chem. 274 1999 25167 25172
5. O. Saksela, and D.B. Rifkin Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity J. Cell Biol. 110 1990 767 775
6. A. Yayon, M. Klagsbrun, J.D. Esko, P. Leder, and D.M. Ornitz Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor Cell 64 1991 841 848
7. M. Fannon, and M. Nugent Basic fibroblast growth factor binds its receptors, is internalized, and stimulates DNA synthesis in Balb/c3T3 cells in the absence of heparan sulfate J. Biol. Chem. 271 1996 17949 17956
8. D. Moscatelli High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells J. Cell. Physiol. 131 1987 123 130
9. A. Rapraeger, A. Krufka, and B. Olwin Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation Science 252 1991 1705 1708
10. G. Sperinde, and M. Nugent Heparan sulfate proteoglycans control intracellular processing of bFGF in vascular smooth muscle cells Biochemistry 37 1998 13153 13164
11. J. Kuhn, K. Mölle, T. Brinkmann, C. Götting, and K. Kleesiek High-density tissue-like cultivation of JAR choriocarcinoma cells for the in vitro production of human xylosyltransferase J. Biotechnol. 103 2003 191 196
12. M. Butler, and M. Dawson Cell Culture Labfax 1992 Bios Scientific Publishers (Academic Press) Oxford, England
13. J. Kuhn, S. Müller, M. Schnölzer, T. Kempf, S. Schön, T. Brinkmann, M. Schöttler, C. Götting, and K. Kleesiek High-level expression and purification of human xylosyltransferase I in High Five insect cells as biochemically active form Biochem. Biophys. Res. Commun. 312 2003 537 544
14. A.E. Kearns, S.C. Campbell, J. Westley, and N.B. Schwartz Initiation of chondroitin sulfate biosynthesis: a kinetic analysis of UDP-d-xylose: core protein beta-d-xylosyltransferase Biochemistry 30 1991 7477 7483
15. A.E. Kearns, B.M. Vertel, and N.B. Schwartz Topography of glycosylation and UDP-xylose production J. Biol. Chem. 268 1993 11097 11104
16. C. Götting, S. Sollberg, J. Kuhn, C. Huerkamp, T. Brinkmann, T. Krieg, and K. Kleesiek Serum xylosyltransferase: a new biochemical marker of the sclerotic process in systemic sclerosis J. Invest. Dermatol. 112 1999 919 924
17. H. Kähnert, R. Paddenberg, and K. Kleesiek Simultaneous secretion of xylosyltransferase and chondroitin sulfate proteoglycans in chondrocyte culture Eur. J. Clin. Chem. Clin. Biochem. 29 1991 624 625
18. E.R. Lazarowski, D.A. Shea, R.C. Boucher, and T.K. Harden Release of cellular UDP-glucose as a potential extracellular signaling molecule Mol. Pharmacol. 63 2003 1190 1197
19. K. Kleesiek, R. Reinards, J. Okusi, B. Wolf, and H. Greiling UDP-d-xylose: proteoglycan core protein β-d-xylosyltransferase: a new marker of cartilage destruction in chronic joint Clin. Chem. Clin. Biochem. 25 1987 473 481
20. J. Kuhn, C. Götting, M. Schnölzer, T. Kempf, T. Brinkmann, and K. Kleesiek First isolation of human UDP-d-xylose: proteoglycan core protein β-d-xylosyltransferase secreted from cultured JAR choriocarcinoma cells J. Biol. Chem. 276 2001 4940 4947
21. T. Kojima, A. Katsumi, T. Yamazaki, T. Muramatsu, T. Nagasaka, K. Ohsumi, and H. Saito Human ryudocan from endothelium-like cells binds basic fibroblast growth factor, midkine, and tissue factor pathway inhibitor J. Biol. Chem. 271 1996 5914 5920
22. T.A. Mitsiadis, M. Salmivirta, T. Muramatsu, H. Muramatsu, H. Rauvala, E. Lehtonen, M. Jalkanen, and I. Thesleff Expression of the heparin-binding cytokines, midkine (MK) and HB-GAM (pleiotrophin) is associated with epithelial-mesenchymal interactions during fetal development and organogenesis Development 121 1995 37 51
23. P. Jemth, J. Kreuger, M. Kusche-Gullberg, L. Sturiale, G. Gimenez-Gallego, and U. Lindahl Biosynthetic oligosaccharide libraries for identification of protein-binding heparan sulfate motifs. Exploring the structural diversity by screening for fibroblast growth factor (FGF)1 and FGF2 binding J. Biol. Chem. 277 2002 30567 30573
24. D.A. Pye, R.R. Vives, P. Hyde, and J.T. Gallagher Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: differential requirements for the modulation of FGF-1 and FGF-2 Glycobiology 10 2000 1183 1192
25. D.A. Pye, R.R. Vives, J.E. Turnbull, P. Hyde, and J.T. Gallagher Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity J. Biol. Chem. 273 1998 2936 22942
26. C. Richard, M. Roghani, and D. Moscatelli Fibroblast growth factor (FGF)-2 mediates cell attachment through interactions with two FGF receptor-1 isoforms and extracellular matrix or cell-associated heparan sulfate proteoglycans Biochem. Biophys. Res. Commun. 276 2000 399 405
27. J.E. Turnbull, D.G. Fernig, Y. Ke, M.C. Wilkinson, and J.T. Gallagher Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate J. Biol. Chem. 267 1992 10337 10341
28. A. Walker, J.E. Turnbull, and J.T. Gallagher Specific heparan sulfate saccharides mediate the activity of basic fibroblast growth factor J. Biol. Chem. 269 1994 931 935
29. S. Ye, Y. Luo, W. Lu, R.B. Jones, R.J. Linhardt, I. Capila, T. Toida, M. Kan, H. Pelletier, and W.L. McKeehan Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs Biochemistry 40 2001 14429 14439
30. S. Faham, R.E. Hileman, J.R. Fromm, R.J. Linhardt, and D.C. Rees Heparin structure and interactions with basic fibroblast growth factor Science 271 1996 1116 1120
31. M.A. Nugent, and R.V. Iozzo Fibroblast growth factor-2 IJBCB 32 2000 115 120
32. A. Bikfalvi, S. Klein, G. Pintucci, and D.B. Rifkin Biological roles of fibroblast growth factor-2 Endocr. Rev. 18 1997 26 45
33. H.E. Conrad Heparin-Binding Proteins 1998 Academic Press San Diego
34. C.J. Dowd, C.L. Cooney, and M.A. Nugent Heparan sulfate mediates bFGF transport through basement membrane by diffusion with rapid reversible binding J. Biol. Chem. 274 1999 5236 5244
35. F.J. Moy, A.P. Seddon, P. Bohlen, and R. Powers High-resolution solution structure of basic fibroblast growth factor determined by multidimensional heteronuclear magnetic resonance spectroscopy Biochemistry 35 1996 13552 13561
36. J.A. Abraham, J.L. Whang, A. Tumolo, A. Mergia, J. Friedman, D. Gospodarowicz, and J.C. Fiddes Human basic fibroblast growth factor: nucleotide sequence and genomic organization EMBO J. 5 1986 2523 2528
37. Y. Duraisamy, J. Gaffney, M. Slevin, C.A. Smith, K. Williamson, and N. Ahmed Aminosalicylic acid reduces the antiproliferative effect of hyperglycaemia, advanced glycation endproducts and glycated basic fibroblast growth factor in cultured bovine aortic endothelial cells: comparison with aminoguanidine Mol. Cell. Biochem. 246 2003 143 153
38. Y. Duraisamy, M. Slevin, N. Smith, J. Bailey, J. Zweit, C. Smith, N. Ahmed, and J. Gaffney Effect of glycation on basic fibroblast growth factor induced angiogenesis and activation of associated signal transduction pathways in vascular endothelial cells: possible relevance to wound healing in diabetes Angiogenesis 4 2001 277 288
39. F. Facchiano, A. Lentini, V. Fogliano, S. Mancarella, C. Rossi, A. Facchiano, and M.C. Capogrossi Sugar-induced modification of fibroblast growth factor 2 reduces its angiogenic activity in vivo Am. J. Pathol. 161 2002 531 541
40. I. Giardino, D. Edelstein, and M. Brownlee Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes J. Clin. Invest. 94 1994 110 117
41. N.N. Nissen, R. Shankar, R.L. Gamelli, A. Singh, and L.A. DiPietro Heparin and heparan sulphate protect basic fibroblast growth factor from non-enzymic glycosylation Biochem. J. 338 1999 637 642
42. G. Pintucci, N. Quarto, and D.B. Rifkin Methylation of high molecular weight fibroblast growth factor-2 determines post-translational increases in molecular weight and affects its intracellular distribution Mol. Biol. Cell 7 1996 1249 1258